PIVOTAL trial: iron loading improves clinical outcomes

Research output: Contribution to journalArticle

Abstract

The PIVOTAL trial shows that proactive intravenous (i.v.) iron administration reduces cardiovascular events and deaths, transfusions and erythropoiesis-stimulating agent doses and does not increase infections in patients on haemodialysis. These findings upend the warnings of guidelines and experts about the dangers of i.v. iron and prove that maintaining low iron stores is harmful.

Original languageEnglish
Pages (from-to)260-261
Number of pages2
JournalNature Reviews Nephrology
Volume15
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint Dive into the research topics of 'PIVOTAL trial: iron loading improves clinical outcomes'. Together they form a unique fingerprint.

  • Cite this